BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 31628846)

  • 1. A Balanced Translocation in Kallmann Syndrome Implicates a Long Noncoding RNA, RMST, as a GnRH Neuronal Regulator.
    Stamou M; Ng SY; Brand H; Wang H; Plummer L; Best L; Havlicek S; Hibberd M; Khor CC; Gusella J; Balasubramanian R; Talkowski M; Stanton LW; Crowley WF
    J Clin Endocrinol Metab; 2020 Mar; 105(3):e231-44. PubMed ID: 31628846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defects in GnRH Neuron Migration/Development and Hypothalamic-Pituitary Signaling Impact Clinical Variability of Kallmann Syndrome.
    Kałużna M; Budny B; Rabijewski M; Kałużny J; Dubiel A; Trofimiuk-Müldner M; Wrotkowska E; Hubalewska-Dydejczyk A; Ruchała M; Ziemnicka K
    Genes (Basel); 2021 Jun; 12(6):. PubMed ID: 34198905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gli3 Regulates Vomeronasal Neurogenesis, Olfactory Ensheathing Cell Formation, and GnRH-1 Neuronal Migration.
    Taroc EZM; Naik AS; Lin JM; Peterson NB; Keefe DL; Genis E; Fuchs G; Balasubramanian R; Forni PE
    J Neurosci; 2020 Jan; 40(2):311-326. PubMed ID: 31767679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Forebrain gonadotropin-releasing hormone neuronal development: insights from transgenic medaka and the relevance to X-linked Kallmann syndrome.
    Okubo K; Sakai F; Lau EL; Yoshizaki G; Takeuchi Y; Naruse K; Aida K; Nagahama Y
    Endocrinology; 2006 Mar; 147(3):1076-84. PubMed ID: 16293668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functionally compromised CHD7 alleles in patients with isolated GnRH deficiency.
    Balasubramanian R; Choi JH; Francescatto L; Willer J; Horton ER; Asimacopoulos EP; Stankovic KM; Plummer L; Buck CL; Quinton R; Nebesio TD; Mericq V; Merino PM; Meyer BF; Monies D; Gusella JF; Al Tassan N; Katsanis N; Crowley WF
    Proc Natl Acad Sci U S A; 2014 Dec; 111(50):17953-8. PubMed ID: 25472840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diversity in fibroblast growth factor receptor 1 regulation: learning from the investigation of Kallmann syndrome.
    Kim SH; Hu Y; Cadman S; Bouloux P
    J Neuroendocrinol; 2008 Feb; 20(2):141-63. PubMed ID: 18034870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Congenital hypogonadotropic hypogonadism in a patient with a de novo POGZ mutation.
    Eskici N; Madhusudan S; Vaaralahti K; Yellapragada V; Gomez-Sanchez C; Kärkinen J; Almusa H; Brandstack N; Miettinen PJ; Wang Y; Raivio T
    Eur J Endocrinol; 2023 Aug; 189(2):271-280. PubMed ID: 37619992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysfunctional SEMA3E signaling underlies gonadotropin-releasing hormone neuron deficiency in Kallmann syndrome.
    Cariboni A; André V; Chauvet S; Cassatella D; Davidson K; Caramello A; Fantin A; Bouloux P; Mann F; Ruhrberg C
    J Clin Invest; 2015 Jun; 125(6):2413-28. PubMed ID: 25985275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical manifestations of impaired GnRH neuron development and function.
    Kim HG; Bhagavath B; Layman LC
    Neurosignals; 2008; 16(2-3):165-82. PubMed ID: 18253056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The importance of autosomal genes in Kallmann syndrome: genotype-phenotype correlations and neuroendocrine characteristics.
    Oliveira LM; Seminara SB; Beranova M; Hayes FJ; Valkenburgh SB; Schipani E; Costa EM; Latronico AC; Crowley WF; Vallejo M
    J Clin Endocrinol Metab; 2001 Apr; 86(4):1532-8. PubMed ID: 11297579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversible kallmann syndrome, delayed puberty, and isolated anosmia occurring in a single family with a mutation in the fibroblast growth factor receptor 1 gene.
    Pitteloud N; Acierno JS; Meysing AU; Dwyer AA; Hayes FJ; Crowley WF
    J Clin Endocrinol Metab; 2005 Mar; 90(3):1317-22. PubMed ID: 15613419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Kallmann syndrome with deafness caused by SOX10 mutation: Advances in research].
    Zhou X; Li WW; Wu QY; Yu MM; Xia XY
    Zhonghua Nan Ke Xue; 2017 Sep; 23(9):838-841. PubMed ID: 29726667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kallmann syndrome associated with complex chromosome rearrangement.
    Casamassima AC; Wilmot PL; Vibert BK; Shapiro LR
    Am J Med Genet; 1993 Mar; 45(5):539-41. PubMed ID: 8456820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FGFR1 mutations in Kallmann syndrome.
    Villanueva C; de Roux N
    Front Horm Res; 2010; 39():51-61. PubMed ID: 20389085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations in fibroblast growth factor receptor 1 cause Kallmann syndrome with a wide spectrum of reproductive phenotypes.
    Pitteloud N; Meysing A; Quinton R; Acierno JS; Dwyer AA; Plummer L; Fliers E; Boepple P; Hayes F; Seminara S; Hughes VA; Ma J; Bouloux P; Mohammadi M; Crowley WF
    Mol Cell Endocrinol; 2006 Jul; 254-255():60-9. PubMed ID: 16764984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ontogeny of GnRH and olfactory neuronal systems in man: novel insights from the investigation of inherited forms of Kallmann's syndrome.
    González-Martínez D; Hu Y; Bouloux PM
    Front Neuroendocrinol; 2004 Jul; 25(2):108-30. PubMed ID: 15571757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss-of-function mutations in SOX10 cause Kallmann syndrome with deafness.
    Pingault V; Bodereau V; Baral V; Marcos S; Watanabe Y; Chaoui A; Fouveaut C; Leroy C; Vérier-Mine O; Francannet C; Dupin-Deguine D; Archambeaud F; Kurtz FJ; Young J; Bertherat J; Marlin S; Goossens M; Hardelin JP; Dodé C; Bondurand N
    Am J Hum Genet; 2013 May; 92(5):707-24. PubMed ID: 23643381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A cryptic microdeletion del(12)(p11.21p11.23) within an unbalanced translocation t(7;12)(q21.13;q23.1) implicates new candidate loci for intellectual disability and Kallmann syndrome.
    Ben-Mahmoud A; Kishikawa S; Gupta V; Leach NT; Shen Y; Moldovan O; Goel H; Hopper B; Ranguin K; Gruchy N; Maas SM; Lacassie Y; Kim SH; Kim WY; Quade BJ; Morton CC; Kim CH; Layman LC; Kim HG
    Sci Rep; 2023 Aug; 13(1):12984. PubMed ID: 37563198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Point mutations in KAL1 and the mitochondrial gene MT-tRNA(cys) synergize to produce Kallmann syndrome phenotype.
    Wang F; Huang GD; Tian H; Zhong YB; Shi HJ; Li Z; Zhang XS; Wang H; Sun F
    Sci Rep; 2015 Aug; 5():13050. PubMed ID: 26278626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SEMA3A, a gene involved in axonal pathfinding, is mutated in patients with Kallmann syndrome.
    Hanchate NK; Giacobini P; Lhuillier P; Parkash J; Espy C; Fouveaut C; Leroy C; Baron S; Campagne C; Vanacker C; Collier F; Cruaud C; Meyer V; García-Piñero A; Dewailly D; Cortet-Rudelli C; Gersak K; Metz C; Chabrier G; Pugeat M; Young J; Hardelin JP; Prevot V; Dodé C
    PLoS Genet; 2012 Aug; 8(8):e1002896. PubMed ID: 22927827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.